Daniel Wilson serves as the Chief Financial Officer at iRhythm Technologies Inc., a leading digital health company focused on providing ambulatory cardiac monitoring solutions. In his role, Wilson is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, and investor relations. His strategic vision and financial acumen have been instrumental in guiding iRhythm through periods of significant growth and innovation. Before joining iRhythm Technologies, Wilson held several high-profile positions in the finance sector. He previously served as the Vice President of Finance at a prominent medical device company, where he played a key role in driving the organization's financial strategy and expansion efforts. Wilson's career also includes stints at top-tier financial institutions, where he honed his skills in corporate finance and strategic planning. His extensive experience in both the healthcare and finance industries makes him a valuable asset to iRhythm Technologies. Under Wilson's leadership, iRhythm has achieved notable milestones, including successful product launches and strengthened market positions. His ability to navigate complex financial landscapes and his commitment to fostering a culture of transparency and accountability have earned him respect among colleagues and industry peers alike. As iRhythm continues to innovate and expand its reach, Wilson's role as CFO remains pivotal in ensuring the company's sustained success and financial health.